Brief: Equillium Reports Q2 2022 Results
Aug 15 (Reuters) - Equillium Inc EQ.O :
* EQUILLIUM REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES CLINICAL DEVELOPMENT UPDATES
* Q2 LOSS PER SHARE $0.41
* EQUILLIUM - BELIEVES CASH,INVESTMENTS, WITH ITS EXISTING
AND
AVAILABLE COMMITTED EQUITY LINE, SUFFICIENT TO FUND ITS
OPERATIONS FOR AT LEAST NEXT 12 MONTHS
Source text for Eikon: ID:nBw1xxCs3a
Further company coverage: EQ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Equillium
See all newsBrief: Equillium Receives Australian Regulatory Clearance To Initiate First-In-Human Clinical Trial Of Eq504
Equillium Inc reports results for the quarter ended June 30 - Earnings Summary
Equillium Q2 post narrower net loss than expected; starts R&D initiatives
Equillium Inc expected to post a loss of 5 cents a share - Earnings Preview
Equillium Q1 net loss, profit miss analyst expectations